Al-Batran, S., Hofheinz, R., & Bildat, S. (2021). Quality of life and outcome of patients with metastatic pancreatic cancer receiving first-line chemotherapy with nab-paclitaxel and gemcitabine: Real-life results from the prospective QOLIXANE trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry. International journal of cancer. https://doi.org/10.1002/ijc.33336
Cytowanie według stylu Chicago (wyd. 17)Al-Batran, Salah-Eddin, Ralf-Dieter Hofheinz, i Stephan Bildat. "Quality of Life and Outcome of Patients with Metastatic Pancreatic Cancer Receiving First-line Chemotherapy with Nab-paclitaxel and Gemcitabine: Real-life Results from the Prospective QOLIXANE Trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer Registry." International Journal of Cancer 2021. https://doi.org/10.1002/ijc.33336.
Cytowanie według stylu MLA (wyd. 8)Al-Batran, Salah-Eddin, et al. "Quality of Life and Outcome of Patients with Metastatic Pancreatic Cancer Receiving First-line Chemotherapy with Nab-paclitaxel and Gemcitabine: Real-life Results from the Prospective QOLIXANE Trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer Registry." International Journal of Cancer, 2021, https://doi.org/10.1002/ijc.33336.